Xtant Medical Holdings (STU:XMS) Cyclically Adjusted PB Ratio: (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:XMS Xtant Medical Holdings Inc STU:XMS
22 GF Score
Price €0.26
GF Value €0.45
! 2 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xtant Medical Holdings  (STU:XMS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Xtant Medical Holdings Cyclically Adjusted PB Ratio Related Terms


Xtant Medical Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Cyclically Adjusted PB Ratio Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xtant Medical Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:XMS vs NNOX, POSC, MDAI: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted PB Ratio falls into.


STU:XMS
22GF Score
Xtant Medical Holdings Inc STU:XMS
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Xtant Medical Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Xtant Medical Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.248/333.9520*333.9520
=0.248

Current CPI (Jun. 2026) = 333.9520.

Xtant Medical Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201609 -4.067 241.428 -5.626
201612 -4.627 241.432 -6.400
201703 -7.182 243.801 -9.838
201706 -12.467 244.955 -16.997
201709 -16.620 246.819 -22.487
201712 -32.483 246.524 -44.003
201803 0.960 249.554 1.285
201806 0.665 251.989 0.881
201809 0.817 252.439 1.081
201812 -2.900 251.233 -3.855
201903 -2.615 254.202 -3.435
201906 -2.742 256.143 -3.575
201909 -2.935 256.759 -3.817
201912 -3.001 256.974 -3.900
202003 -3.158 258.115 -4.086
202006 -3.124 257.797 -4.047
202009 -3.054 260.280 -3.918
202012 0.154 260.474 0.197
202103 0.323 264.877 0.407
202106 0.324 271.696 0.398
202109 0.320 274.310 0.390
202112 0.314 278.802 0.376
202203 0.305 287.504 0.354
202206 0.305 296.311 0.344
202209 0.325 296.808 0.366
202212 0.296 296.797 0.333
202303 0.281 301.836 0.311
202306 0.262 305.109 0.287
202309 0.395 307.789 0.429
202312 0.362 306.746 0.394
202403 0.337 312.332 0.360
202406 0.321 314.175 0.341
202409 0.297 315.301 0.315
202412 0.295 315.605 0.312
202503 0.292 319.799 0.305
202506 0.302 322.561 0.313
202509 0.307 324.800 0.316
202512 0.311 324.054 0.320
202603 0.300 330.213 0.303
202606 0.248 333.952 0.248

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Xtant Medical Holdings (STU:XMS) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of €0.26 is trading 42.2% below its estimated GF Value™ of €0.45.

Key valuation signals for STU:XMS:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.45 vs. price of €0.26 (42.2% below fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the STU:XMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Other Exchanges XTNT:USA
Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
22GF Score

Get the complete analysis for STU:XMS

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.45
GF Value